Literature DB >> 22127831

Nanoparticles of selenium as species with stronger physiological effects in sheep in comparison with sodium selenite.

Sirous Sadeghian1, Gholam Ali Kojouri, Abdonnaser Mohebbi.   

Abstract

The present study was designed to compare the effects of nano red selenium and sodium selenite on the antioxidative activities of neutrophils and the hematological parameters in sheep. Fifteen sheep were randomly allocated into three groups. Groups 1 and 2 received selenium nanoparticles orally at 1 mg/kg and sodium selenite at 1 mg Se/kg for 10 consecutive days; group 3 served as the control. To assess the degrees of oxidative stress and of lipid peroxidation of the cellular membranes, the levels of thiobarbituric acid reactive substances (TBARS) were determined in serum samples that were collected at different supplementation intervals, i.e., after 0, 10, 20, and 30 days. In addition, hematological parameters in the serum samples were measured by routine procedures. It was found that TBARS levels in groups 1 and 2 were significantly higher on days 20 and 30 compared to the basal level on day 0. It was also found that on day 30, the TBARS activities in both treated groups were significantly higher than those of the controls (P < 0.05). These findings may explain the seemingly paradoxical effects of supplemental selenium on the indicators of oxidative stress, as the levels of TBARS were generally expected to decrease in the presence of selenium. There were no significant differences between the PCV and RBC values in the three groups. The white blood cell count (WBC) in group 1 showed a significant increase on days 20 and 30 in comparison with the control group. However, in group 2, there was a significant increase of the WBC value just on day 20 in comparison with the control group. Also, there were significant increases of the neutrophil counts and significant decreases of the lymphocyte counts on day 10 in group 1, in comparison with those in group 2 and controls, and on days 20 and 30 in groups 1 and 2 in comparison with those in the control group.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22127831      PMCID: PMC3332341          DOI: 10.1007/s12011-011-9266-8

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


Introduction

Selenium (Se) as a biocatalyst and functional component of numerous enzymes is needed for the proper functions of the immune system and possesses anticarcinogenic effects [1, 2]. Se functions as a redox center of an array of selenoproteins [3, 4], such as glutathione peroxidase (GPx) [5, 6], phospholipid hydroperoxide glutathione peroxidase [7, 8], and thioredoxin reductase [9, 10]. Nano-selenium (nano-Se) possesses equal efficacy in increasing the activities of GPx in plasma and liver from mice compared with selenomethionine [11]. Subsequent studies demonstrated that the activity of nano-elemental Se in upregulating selenoenzymes is comparable to that of selenite, selenomethionine, and methylselenocysteine, while exhibiting dramatically decreased acute toxicity [11-14]. Oxidative stress usually is defined as an increased formation of reactive oxygen species and/or decreased antioxidant defense. While cells and biological fluids have an array of protective antioxidant mechanisms, several methods for serum antioxidative activity determination have been developed. Most have been based on reduced production of thiobarbituric acid reactive substances (TBARS) [15]. What should be noted about the changes in hematological parameters is the effect of selenium on survivability of the RBCs. As a result, the present study was designed to determine hematological changes and the levels of oxidative stress and lipid peroxidation of cellular membrane changes in healthy sheep in response to selenium nanoparticles and sodium selenite supplementation using TBARS assay.

Materials and Methods

Animals

Fifteen healthy, 5- to 12-month-old Lori–Bakhtiari sheep were selected and randomly divided into three groups. The sheep were orally given nano red selenium (group I, 1 mg/kg BW) and sodium selenite (group II, 1 mg Se/kg BW) for 10 consecutive days. The control group was given distilled water (group III).

Ration

During the study period, sheep were fed alfalfa hay and barely without selenium supplementation. The mean value of Se (mean ± SE) in the diet on dry matter basis was 0.49 ± 0.15 mg/kg.

Nano Red Selenium Preparation

Nano red elemental selenium particles (nano-Se) were synthesized as described previously by Zhang et al. [16]. The material includes SeO2 and ascorbic acid. The ascorbic acid solution was added into the aqueous solution of SeO2 to initiate the reaction. After the addition of ascorbic acid, nano red selenium particles began to form, causing the solutions to change from colorless to red. The red color of the ascorbic acid-treated solutions suggested that the selenium was present either in its amorphous or monoclinic forms [16]. The sizes of the obtained nano-Se particles ranged from 80 to 200 nm as determined by scanning electron microscopy.

Sampling

Two blood samples were collected from the jugular vein of sheep into acid-washed polyethylene tubes at the beginning of the experiment (day 0) and subsequently on days 10, 20, and 30. One tube contained heparin as the anticoagulation agent for hematological parameter analyses, and the other tube was without anticoagulation, for measuring TBARS.

TBARS Assay

Sample Preparation

A serum sample of 0.5 ml was mixed with 0.5 ml sterile distilled water in a labeled 1.5-ml micro-centrifuge tube. A blank sample (for calibration) was also prepared by adding 2 ml of the reagent to 1 ml distilled water.

Reagent Preparation

Trichloroacetic acid (10%) (w/v), 0.375% thiobarbituric acid (TBA) (w/v), and 0.025 N HCl were mixed and heated gently until TBA was dissolved completely.

Performing Assay

Two milliliters of the reagent was added to each sample, and the microtubes were incubated in a boiling water bath for 10 min. Then they were placed at room temperature for 15 min and centrifuged at 1,000×g for 10 min at 4°C. Finally, the supernatants were transferred to new labeled tubes, and absorbances of the samples were measured at 535 nm against a blank sample. Antioxidative activity was calculated by adding the malondialdehyde index (1.056 × 105 M−1 cm−1).

Hematological Parameter Assay

Hematological parameters including red blood cell (RBC) count, packed cell volume (PCV) value, hemoglobin (Hb) concentration, and white blood cell (WBC) counts were measured by routine procedures [17]. Hemoglobin was measured photometrically using the cyanomethemoglobin method, and PCV levels were determined using a microhematocrit centrifuge (12,000×g for 5 min). WBC measurement was conducted using the manual standard method. Differential leukocyte counts were performed on routinely prepared Geimsa-stained blood films using the cross-sectional technique [18].

Statistical Analysis

The results were analyzed statistically using the Sigma State (second version) program and by one-way analysis of variance tests. Also, the Tukey test and Dunnett's method were used for further evaluations at the level P < 0.05.

Results

TBARS

The observed TBARS values in each group on different days of sampling are presented in Table 1. It should be noted that there were no significant differences in the TBARS values of the three groups at the beginning of the experiment (day 0) and on the 10th day, but a significant increase had occurred in groups 1 and 2 in comparison with the basal level on the 20th and 30th day (P < 0.05). In group 1 (nano-selenium), on the 20th and 30th day, the values of TBARS were increased to 0.187 ± 0.032 and 0.184 ± 0.012, respectively (P < 0.05), in comparison with the basal level (0.122 ± 0.006). The statistical survey showed that there were no significant differences on the 10th day in comparison with day 0, but a significant increase was observed in the values of TBARS on the 20th day in comparison with day 0 (P = 0.002) and the 30th day compared with day 0 (P < 0.001). Besides, a significant increase was observed on the 20th (P = 0.042) and 30th day (P = 0.024) in comparison with the 10th day. These results show that the maximum values of TBARS occurred on day 20 and less antioxidant properties, in day 20. In group 2 (sodium selenite), TBARS value was increased slightly on the 10th day as it reached from 0.125 ± 0.007 (day 0) to 0.146 ± 0.118 on the 10th day (P > 0.05). An ascending trend in TBARS value occurred on the 20th and 30th day and reached to 0.192 ± 0.047 and 0.199 ± 0.035, respectively (P < 0.05). A significant increase on the 20th day in comparison with day 0 (P = 0.013) and on the 30th day in comparison with day 0 (P = 0.002) was also seen. In the control group, there were no significant differences in the TBARS value on any of the sampling days, neither with the basal level (day 0) nor with each other. By comparing the means of the three groups together, it was determined that there were no significant differences in the TBARS values on the 0, 10th, and 20th day (P > 0.05), while in groups 1 and 2, a significant increase in the TBARS values was seen just on the 30th day in comparison with the control group, with P = 0.003 and P = 0.011, respectively.
Table 1

The changes in mean + SD of TBARS value in each of the groups during the different days of sampling

Sampling daysGroup 1 (nano-selenium)Group 2 (sodium selenite)Control
00.122 ± 0.0060.125 ± 0.0070.124 ± 0.007
100.133 ± 0.0390.146 ± 0.1180.135 ± 0.012
200.187 ± 0.032*,** 0.192 ± 0.047* 0.145 ± 0.027
300.184 ± 0.012*,**,*** 0.199 ± 0.035*,*** 0.141 ± 0.018
P value<0.05<0.05>0.05

*P < 0.05, significant increase to day 0; **P < 0.05, significant increase to day 10; ***P < 0.05, significant increase to the control group

The changes in mean + SD of TBARS value in each of the groups during the different days of sampling *P < 0.05, significant increase to day 0; **P < 0.05, significant increase to day 10; ***P < 0.05, significant increase to the control group

Hematological Parameters

The observed PCV, RBC, WBC, neutrophil, and lymphocyte counts in each group on different days of sampling are presented in Table 2, 3, 4, 5, and 6.
Table 2

PCV counts (means ± SD) in each of the groups during the different days of sampling

Sampling daysGroup 1 (nano-selenium)Group 2 (sodium selenite)Control
032.00 ± 1.22530.400 ± 1.51730.00 ± 2.550
1033.00 ± 2.34530.800 ± 2.95030.400 ± 3.647
2030.400 ± 1.14031.600 ± 3.78229.400 ± 3.050
3031.800 ± 0.83728.400 ± 3.28629.200 ± 3.701
P value>0.05>0.05>0.05
Table 3

Red blood cell counts (means ± SD) in each of the groups during the different days of sampling

Sampling daysGroup 1 (nano-selenium)Group 2 (sodium selenite)Control
011.300 ± 0.41210.820 ± 0.49210.660 ± 0.853
1011.660 ± 0.81110.900 ±0.93510.820 ± 1.260
2010.780 ± 0.43211.220 ± 1.24810.520 ± 1.040
3011.240 ± 0.28810.120 ± 1.11710.380 ± 1.184
P value>0.05>0.05>0.05
Table 4

White blood cell counts (means ± SD) in each of the groups during the different days of sampling

Sampling daysGroup 1 (nano-selenium)Group 2 (sodium selenit)Control
07,460 ± 497.9967,420 ± 449.4447,440 ± 602.495
108,640 ± 879.204* 8,380 ± 785.493* 7,560 ± 795.613
209,020 ± 491.935*,** 8,540 ± 931.665*,** 7,420 ± 521.536
308,580 ± 349.285*,** 8,100 ± 768.1157,500 ± 768.115
P value<0.05<0.05>0.05

*P < 0.05, significant increase to day 0; **P < 0.05, significant increase to the control group

Table 5

Neutrophil counts (means ± SD) in each of the groups during the different days of sampling

Sampling daysGroup 1 (nano-selenium)Group 2 (sodium selenite)Control
033.200 ± 1.92432.400 ± 1.81734.200 ± 2.864
1043.200 ± 3.701*,***,**** 37.800 ± 3.701* 35.00 ± 7.00
2063.00 ± 10.840*,**,**** 55.200 ± 8.289*,**,**** 36.400 ± 1.517
3053.800 ± 6.686*,**,**** 44.600 ± 6.387*,**** 34.400 ± 2.510
P value<0.05<0.05>0.05

*P < 0.05, significant increase to day 0; **P < 0.05, significant increase to day 10; ***P < 0.05, significant increase to group 2 (sodium selenite); ****P < 0.05, significant increase to the control group

Table 6

Lymphocyte counts (means ± SD) in each of the groups during the different days of sampling

Sampling daysGroup 1 (nano-selenium)Group 2 (sodium selenite)Control
063.800 ± 1.92465.400 ± 0.89463.800 ± 2.588
1053.600 ± 3.507*,****,***** 59.800 ± 2.168* 62.200 ± 6.723
2034.200 ± 10.498*,**,***** 41.800 ± 9.230*,**,***** 61.800 ± 2.775
3034.200 ± 10.498*,**,***** 53.400 ± 6.107*,***,***** 63.600 ± 2.881
P value<0.05<0.05>0.05

*P < 0.05, significant reduction to day 0; **P < 0.05, significant reduction to day 10; ***P < 0.05, significant increase to day 20; ****P < 0.05, significant reduction to group 2 (sodium selenite); *****P < 0.05, significant reduction to the control group

PCV counts (means ± SD) in each of the groups during the different days of sampling Red blood cell counts (means ± SD) in each of the groups during the different days of sampling White blood cell counts (means ± SD) in each of the groups during the different days of sampling *P < 0.05, significant increase to day 0; **P < 0.05, significant increase to the control group Neutrophil counts (means ± SD) in each of the groups during the different days of sampling *P < 0.05, significant increase to day 0; **P < 0.05, significant increase to day 10; ***P < 0.05, significant increase to group 2 (sodium selenite); ****P < 0.05, significant increase to the control group Lymphocyte counts (means ± SD) in each of the groups during the different days of sampling *P < 0.05, significant reduction to day 0; **P < 0.05, significant reduction to day 10; ***P < 0.05, significant increase to day 20; ****P < 0.05, significant reduction to group 2 (sodium selenite); *****P < 0.05, significant reduction to the control group

The PCV and RBC Counts

In the three groups, there were no significant differences in the PCV and RBC counts on any of the sampling days, neither with the basal level (day 0) nor with each other.

Number of WBC

In group 1 (nano-selenium), on the 10th and 20th day, the numbers of WBC increased to 8,640 ± 879.204 and 9,020 ± 491.935, respectively (P < 0.05), in comparison with the basal level (7,460 ± 497.996). The statistical survey showed that there was a significant increase in WBC counts on the 10th, 20th, and 30th day in comparison with day 0 with P = 0.031, P = 0.002, and P = 0.003, respectively. As Table 4 clearly shows, in group 1, the WBC counts decreased from the 20th day on, but statistically, there were no significant differences between the 20th and 30th day (P > 0.05). The statistical survey in group 2 (sodium selenite) showed that there was a significant increase on the 10th and 20th day in comparison to day 0 (the P value was 0.045 and 0.023, respectively), and unlike group 1, there was no significant difference in the 30th day in comparison to day 0. In the control group, there were no significant differences in the WBC counts on any of the sampling days, neither with the basal level (day 0) nor with each other. By comparing the means of the three groups together, it was determined that there were no significant differences in the WBC counts on day 0 (P > 0.05). The WBC counts in group 1 showed a significant increase on the 20th and 30th day in comparison with the control group (the P value was 0.001 and 0.021, respectively), while in group 2, a significant increase in the WBC counts was seen just on the 20th day in comparison with the control group (P = 0.047).

The Neutrophil Counts

Table 5 shows that the number of neutrophils in groups 1 and 2 increased in the period between days 0 and 20, but this increase was more significant in the nano-selenium group (the P value was <0.001 in each of the three groups). The statistical survey in group 1 (nano-selenium) showed that there was a significant increase in neutrophil counts on the 10th, 20th, and 30th day in comparison with day 0 (the P value was <0.001 in each of the three groups), on the 20th day in comparison with the 10th day (P = 0.005), and on the 30th day in comparison with the 10th day (P = 0.015). In group 2 (sodium selenite), there was significant increase on the 10th, 20th, and 30th days in comparison with day 0 (the P value was 0.019, <0.001, and 0.003, respectively) and on the 20th day in comparison with the 10th day (P = 0.003), but unlike group 1, there was no significant difference on the 30th day in comparison to the 10th day. In the control group, there were no significant differences in the neutrophil counts on any of the sampling days, neither with the basal level (day 0) nor with each other. By comparing the means of the three groups together, it was determined that there were no significant differences in the neutrophil counts on day 0 (P > 0.05). The neutrophil counts in group 1 showed a significant increase on the 10th day in comparison with the two groups (P = 0.050) and control (P = 0.049) group, on the 20th and 30th day compared with control group (the P value was <0.001 and <0.001, respectively), and in group 2 on the 20th and 30th day (the P value was 0.001 and 0.010, respectively) in comparison with the control group.

Number of Lymphocytes

Table 6 shows that the number of lymphocytes in groups 1 and 2 decreased in the period between days 0 and 20, but this decrease was more significant in the sodium selenite group (the P value was <0.001 in each of the three groups). The statistical survey in group 1 (nano-selenium) showed that there was a significant decrease in lymphocyte counts on the 10th, 20th, and 30th day in comparison with day 0 (the P value was <0.001 in each of the three groups), on the 20th day in comparison with the 10th day (P = 0.004), and on the 30th day in comparison with the 10th day (P = 0.030). In group 2 (sodium selenite), there was significant decrease on the 10th, 20th, and 30th day in comparison with day 0 (the P value was <0.001, <0.001, and 0.002, respectively) and on the 20th day in comparison with the 10th day (P = 0.003), but unlike group 1, there was no significant difference on the 30th day in comparison to the 10th day, but in group 2, there was significant increase on the 30th day in comparison to the 20th day (P = 0.047). In the control group, there were no significant differences in the lymphocyte counts on any of the sampling days, neither with the basal level (day 0) nor with each other. By comparing the means of the three groups together, it was determined that there were no significant differences in the lymphocyte counts on day 0 (P > 0.05). The lymphocyte counts in group 1 showed a significant decrease on the 10th day in comparison with those in group 2 (P = 0.010) and the controls (P = 0.035) and in group 1 on the 20th and 30th day, in comparison with the control group, with P values of <0.001 and <0.001, respectively, and in group 2 on the 20th and 30th day, in comparison with the control group, with P values of 0.002 and 0.010, respectively.

Discussion

Se is important for the control of oxidative stress and therefore the redox state of the cell, due to its incorporation as selenocysteine to GSH-Px [19] and thioredoxin reductase [20]. Selenium, as an essential micronutrient in animals, has three levels of biological activities: (1) trace levels are required for normal growth and development, (2) nutritional and supra-nutritional levels can be stored, and homeostatic functions will be maintained, and (3) toxic levels can result in harmful effects [21]. TBARS in biological specimens, including lipid hydroperoxides and aldehydes, increase as a result of oxidative stress. Indeed, plasma concentrations of TBARS are an index of lipid peroxidation and oxidative stress. TBARS return to normal levels over time, depending upon the antioxidants [22, 23]. In this study, the TBARS value in group 1 (nano-selenium) was reduced after the 20th day, but in group 2 (sodium selenite), the TBARS value was in a high level till the 30th day. Therefore, in group 2, the return of TBARS to the basal level has been done with more delay, and it shows the better antioxidative activity of selenium nanoparticles in comparison with sodium selenite. Kumar et al. indicated that Se had no effect on serum total protein, albumin/globulin ratio, and SGPT and SGOT activities but could increase the capacity of the immune system to protect cells from free radical injuries [24]. Huang et al. showed that the elemental Se nanoparticles have significant effects on both the scavenging of the free radicals and the protection of DNA against oxidation, dependent upon size: the smaller, the better [25]. The major result of increasing phagocytic activities of polynuclear cells, especially neutrophils, which are the first body defensive barriers, is an increase in oxidative pressure [26]. Also, respiratory burst, which occurred in neutrophils, can release oxygen free radicals that play a major role in pathogenesis of foreign agents. When neutrophils interact with foreign agents, hundreds of times more oxygen may be released than in their resting state. This causes increasing activation of the NADPH oxidase enzyme on the cell surface. Toxic materials that are produced in neutrophils are severely destructive and cause neutrophil membrane destruction. Selenium admixtures can prevent destruction by elimination of toxic materials and free radicals and can reduce toxic material production of neutrophils, lipid peroxidation, and TBARS values [27-29]. Zhang et al. indicated that nano-Se had a weaker interference effect than selenite on antioxidative balance in Se-deficient mice [13]. Selenium, as the functional component of GSH-Px, protects the neutrophils and other blood components against peroxidative damage [27]. Fraga has mentioned that selenium deficiency can increase oxygen free radicals in body tissues [28], the major negative effects of which are on the consistency of biological membranes and the performance of immunity cells [30]. Heyland has suggested selenium meal consumption as a protective antioxidative activity and a way of decreasing acute disease mortality [31]. Selenium is involved in selenoprotein-type structures which include glutathione peroxidase [32], P selenoprotein, and W selenoprotein. These proteins have a protective role against oxidant materials in body cells and cause an increase in the body's cell resistance such as immunity cells against oxidative destruction [33, 34]. In a study, Zhou et al. indicated discrepancy of muscle Se concentration and GSH-Px activity is because only a part of nano-Se was adopted for selenoprotein synthesis and another metabolic pathway of nano-Se differing from sodium selenite and selenomethionine may exist [35]. The most important action Se is its antioxidant effects because it forms selenocysteine, part of the active center of the GPx [36, 37]. GPx is the most important peroxidase for the detoxification of hydroperoxides and lipidic hydroperoxides at the level of the cytosol and mitochondrial matrix [38, 39]. Nano-Se increased the GST activity more efficiently than selenomethionine [11]. The higher antioxidative activity of nano-Se is further evident from the observed decline of the hepatic superoxide dismutase (SOD) activity. Furthermore, nano-Se exhibits stronger inhibitory effects than selenite and simultaneously increases the hepatic GSH (reduced glutathione) concentrations, while no apparent alteration of the GSH levels were observed with selenite [40]. Since SOD and GSH are indicators of oxidative stress, this demonstrates the advantages of nano-Se over other forms of the element. What should be noted about the changes in hematological parameters is the effect of selenium on survivability of the RBCs [41]. Fraga and Lessard have recognized selenium deficiency as a factor in preventing the activity of glutathione peroxidase and increasing the free oxygen radicals in the tissues such as RBCs, which leads to increase the oxidative damage of the tissues [28, 30]. Although the role of selenium in increasing the resistance of the RBCs has been proved and its deficiency has been mentioned as a factor in anemia production, this effect has not been significant when studying the hematological profile in the present study, and the number of RBCs and the hematocrit value in the group getting nano-selenium have been a little more than group 2 (sodium selenite) and the control group, but not statistically significant. It should be mentioned about the changes in the number of neutrophils, lymphocytes, and WBCs, that the type of body immunity system response and the leukogram changes would be different depending on the kind of animal, individual differences, the kind of animal's nutrition, the grade of the animal's involvement, the presence of stress, etc. [42]. Another conclusion that has been obtained about the effect of selenium on blood cells is increasing the number of the cells (WBCs and neutrophils) and maintaining them in a high level for a longer period of time, so that nano-selenium has affected more severely than sodium selenite. The cause is the role of selenium as an anti oxidant and its ability to take care of body cells against antioxidative damages [27]. The researchers know selenium deficiency is an effective factor on the reduction of the lymphocyte reproductive potency and mention that the importing receptor of transferrin (which is effective in the reproduction of lymphocytes) will be reduced in the animals having selenium deficiency [43]. So, the researchers believe that selenium deficiency results in the weakness of immunity system by preventing the lymphocytes reproduction [30]. What should be noted here is that in all of the mentioned researches, selenium has played a role as an additive factor in increasing the lymphocyte reproduction, but according to the results of the present research, the number of lymphocytes has been decreased until the 20th day of responding nano-selenium and sodium selenite. To analyze this event, the role of neutrophils as the first defensive barrier of the body should be noted. An external material can activate specified immunity system when it passes through the intrinsic immunity barrier and is given to specified immunity system as an antigen, therefore not increasing the number of lymphocytes in the present study can be related to significant increase in the number of neutrophils and not encountering of the lymphocytes with any kind of stimulant factor. In addition, although there are potential advantages of nano-Se in living tissue, there are potential disadvantages of nano-Se also.

Conclusions

Based on all the information mentioned regarding the role of selenium, we can say that these materials can be important factors in increasing the resistance and the defensive ability of the intrinsic immunity in sheep. A selenium nanoparticle is more effective on the counts, survival duration, and the activity of neutrophils and increases them. The increase in TBARS value is longer and more severe when caused by sodium selenite than nano-selenium, which shows the better antioxidative effects of selenium nanoparticles. Since, in sheep, selenium nanoparticles were found to be less toxic and more bioactive than selenite, their use in feed instead of other forms of the element may be recommended.
  24 in total

1.  Free radical scavenging efficiency of Nano-Se in vitro.

Authors:  Bo Huang; Jinsong Zhang; Jingwu Hou; Chang Chen
Journal:  Free Radic Biol Med       Date:  2003-10-01       Impact factor: 7.376

Review 2.  Review of selenium toxicity in the aquatic food chain.

Authors:  Steven J Hamilton
Journal:  Sci Total Environ       Date:  2004-06-29       Impact factor: 7.963

3.  Immunochemical distinction of Aloe vera, A. arborescens, and A. chinensis gels.

Authors:  A Yagi; M Tsunoda; T Egusa; K Akasaki; H Tsuji
Journal:  Planta Med       Date:  1998-04       Impact factor: 3.352

4.  Selenium and vitamin E deficiency impair transferrin receptor internalization but not IL-2, IL-2 receptor, or transferrin receptor expression.

Authors:  G M Pighetti; M L Eskew; C C Reddy; L M Sordillo
Journal:  J Leukoc Biol       Date:  1998-01       Impact factor: 4.962

Review 5.  Biochemical function of selenium and its relation to vitamin E.

Authors:  W G Hoekstra
Journal:  Fed Proc       Date:  1975-10

Review 6.  The protective role of selenium on genetic damage and on cancer.

Authors:  K El-Bayoumy
Journal:  Mutat Res       Date:  2001-04-18       Impact factor: 2.433

Review 7.  Glutathione transferases.

Authors:  John D Hayes; Jack U Flanagan; Ian R Jowsey
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

Review 8.  Thioredoxin reductase as a pathophysiological factor and drug target.

Authors:  K Becker; S Gromer; R H Schirmer; S Müller
Journal:  Eur J Biochem       Date:  2000-10

Review 9.  Oxidative stress caused by inactivation of glutathione peroxidase and adaptive responses.

Authors:  Yasuhide Miyamoto; Young Ho Koh; Yong Seek Park; Noriko Fujiwara; Haruhiko Sakiyama; Yoshiko Misonou; Tomomi Ookawara; Keiichiro Suzuki; Koichi Honke; Naoyuki Taniguchi
Journal:  Biol Chem       Date:  2003-04       Impact factor: 3.915

Review 10.  Mechanism and regulation of selenoprotein synthesis.

Authors:  Donna M Driscoll; Paul R Copeland
Journal:  Annu Rev Nutr       Date:  2003-01-08       Impact factor: 11.848

View more
  12 in total

1.  Th1 Immune Response Induction by Biogenic Selenium Nanoparticles in Mice with Breast Cancer: Preliminary Vaccine Model.

Authors:  Mohammad Hossein Yazdi; Mehdi Mahdavi; Elnaz Faghfuri; Mohammad Ali Faramarzi; Zargham Sepehrizadeh; Zuhair Mohammad Hassan; Mehdi Gholami; Ahmad Reza Shahverdi
Journal:  Iran J Biotechnol       Date:  2015-06       Impact factor: 1.671

2.  Selenium Protects Retinal Cells from Cisplatin-Induced Alterations in Carbohydrate Residues.

Authors:  Dilek Akşit; Alper Yazıcı; Hasan Akşit; Esin S Sarı; Arzu Yay; Onur Yıldız; Adil Kılıç; Sıtkı S Ermiş; Kamil Seyrek
Journal:  Balkan Med J       Date:  2016-07-01       Impact factor: 2.021

3.  Effectiveness of selenium on acrylamide toxicity to retina.

Authors:  Mervat Ahmed Ali; Eman Mohamed Aly; Amal Ibrahim Elawady
Journal:  Int J Ophthalmol       Date:  2014-08-18       Impact factor: 1.779

4.  Effects of Supranutritional Selenium Nanoparticles on Immune and Antioxidant Capacity in Sprague-Dawley Rats.

Authors:  Yuyue Jin; Yudan He; Lujie Liu; Wenjing Tao; Geng Wang; Wanjing Sun; Xun Pei; Zhiping Xiao; Haidong Wang; Minqi Wang
Journal:  Biol Trace Elem Res       Date:  2021-01-29       Impact factor: 3.738

5.  Selenium Nanoparticles for Stress-Resilient Fish and Livestock.

Authors:  Biplab Sarkar; Surajit Bhattacharjee; Akshay Daware; Prosun Tribedi; K K Krishnani; P S Minhas
Journal:  Nanoscale Res Lett       Date:  2015-09-23       Impact factor: 4.703

6.  Evaluation of glutathion peroxidase activity, trace minerals and weight gain following administration of selenium compounds in lambs.

Authors:  Pedram Yaghmaie; Aligholi Ramin; Siamak Asri-Rezaei; Asghar Zamani
Journal:  Vet Res Forum       Date:  2017-06-15       Impact factor: 1.054

7.  Antimicrobial activity of biogenically produced spherical Se-nanomaterials embedded in organic material against Pseudomonas aeruginosa and Staphylococcus aureus strains on hydroxyapatite-coated surfaces.

Authors:  Elena Piacenza; Alessandro Presentato; Emanuele Zonaro; Joseph A Lemire; Marc Demeter; Giovanni Vallini; Raymond J Turner; Silvia Lampis
Journal:  Microb Biotechnol       Date:  2017-02-23       Impact factor: 5.813

8.  Biogenic selenium nanoparticles synthesized by Lactobacillus casei ATCC 393 alleviate intestinal epithelial barrier dysfunction caused by oxidative stress via Nrf2 signaling-mediated mitochondrial pathway.

Authors:  Chunlan Xu; Lei Qiao; Li Ma; Yu Guo; Xina Dou; Shuqi Yan; Baohua Zhang; Alexandra Roman
Journal:  Int J Nanomedicine       Date:  2019-06-18

9.  Stimulatory effects of nano-selenium and conjugated linoleic acid ‎ on antioxidant activity, trace minerals, and gene expression response of growing male Moghani lambs.

Authors:  Shirzad Ghaderzadeh; Farzad Mirzaei Aghjehgheshlagh; Saeid Nikbin; Bahman Navidshad
Journal:  Vet Res Forum       Date:  2020-12-15       Impact factor: 1.054

Review 10.  Nano-selenium and its nanomedicine applications: a critical review.

Authors:  Bozena Hosnedlova; Marta Kepinska; Sylvie Skalickova; Carlos Fernandez; Branislav Ruttkay-Nedecky; Qiuming Peng; Mojmir Baron; Magdalena Melcova; Radka Opatrilova; Jarmila Zidkova; Geir Bjørklund; Jiri Sochor; Rene Kizek
Journal:  Int J Nanomedicine       Date:  2018-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.